耐火性儿科斯蒂尔病的药理和非药理治疗方法:范围审查
Elizabeth Twynam-Perkins1, Neil Martin1, Kirsty McLellan1
1Department of Paediatric Rheumatology, Royal Hospital for Children, Glasgow, UK.
Rheumatology advances in practice
|November 24, 2025
概括
耐火性斯蒂尔病的治疗选择,包括巨细胞激活综合征,正在出现. 像epaalumab和JAK抑制剂这样的新疗法显示出希望,但对于这些具有挑战性的儿科病例需要更多的研究.
科学领域:
- 儿科风湿病学 儿科风湿病学
- 免疫学 免疫学 免疫学
- 系统性青少年异常性关节炎
背景情况:
- 系统性青春性异常性关节炎 (SJIA) 或斯蒂尔病,通过IL-1和IL-6抗剂得到改善.
- 一部分患者患有耐药性疾病,呈现为持久性关节炎,巨细胞激活综合征 (MAS) 或间歇性肺病.
研究的目的:
- 进行范围审查,总结治疗耐火儿科斯蒂尔病的证据.
- 识别和分析耐火性SJIA的不同亚型的治疗策略.
主要方法:
- 在数据库中搜索关于耐火斯蒂尔病及其亚型的研究.
- 包括受控试验,非受控试验,以及16岁之前疾病发病的患者的病例系列/报告.
- 提取了关于研究特征,生存,缓解,皮质类固醇减少和不良影响的数据.
主要成果:
- 30篇文章符合纳入标准;对于所有耐火亚型,没有发现任何受控研究.
- 一项试点研究显示,在耐火性MAS中,epapalumab的结果是正面的.
- 组合生物药物和雅努斯激酶 (JAK) 抑制剂在耐火性关节炎中显示出好处;据报道,全源干细胞移植具有显著的风险.
结论:
- 据报道,各种治疗方法如epapaalumab,JAK抑制剂,rituximab和组合生物药物用于耐火性静电症,但证据有限.
- 对于这些具有挑战性的患者子组,通过一致的结果报告和创新的试验设计进行进一步的研究至关重要.
更多相关视频
05:04Enhancing the Development and Growth of Infant Cerebral Palsy Rats Using Selective Spinal Manipulations
Published on: February 2, 2024
929
10:15Conditional Reprogramming of Pediatric Human Esophageal Epithelial Cells for Use in Tissue Engineering and Disease Investigation
Published on: March 22, 2017
7.3K
相关概念视频
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
196
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
196
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
232
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
232
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
179
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
179
01:26Psychosis: Goals of Pharmacotherapy
449
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
449
01:29Inflammatory Bowel Disease IV: Pharmacological Management
452
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
452
01:28Drug Therapy
235
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
235